Crescita Therapeutics (TSX:CTX) Other Net Income (Loss) : C$-0.09 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Other Net Income (Loss)?

Crescita Therapeutics's Other Net Income (Loss) for the three months ended in Mar. 2024 was C$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.09 Mil.

Crescita Therapeutics's quarterly Other Net Income (Loss) increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil) but then declined from Dec. 2023 (C$0.00 Mil) to Mar. 2024 (C$0.00 Mil).

Crescita Therapeutics's annual Other Net Income (Loss) declined from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$-0.00 Mil) but then increased from Dec. 2022 (C$-0.00 Mil) to Dec. 2023 (C$0.00 Mil).

Crescita Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Crescita Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Other Net Income (Loss) Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-0.09	-	-	-

Crescita Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.09 Mil.

Crescita Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines